Compassion, integrity and efficiency are at the center of everything we do to impact the lives of people living with rare cancers. At Ayala, we are dedicated to developing targeted therapies specifically for patients living with rare and aggressive diseases. In combination with next-generation sequencing and our proprietary bioinformatics platform,
Since 1976, we have built a reputation as a trustworthy and truly independent voice for both consumers and health professionals. We stand up for the consumer by serving as a watchdog of the medical and pharmaceutical industries, including the FDA itself. On top of the trends and ahead of the curve, our research will keep you and your family informed